FDA refuses to review Moderna flu vaccine

Ella Jeffries / beckershospitalreview - Moderna has received a refusal-to-file letter from the FDA’s Center for Biologics Evaluation and Research for its biologics license application for mRNA-1010, its investigational seasonal influenza vaccine. The letter, signed by Vinayak Prasad, MD, chief …

AI Summary: Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making.

#healthcare #pharmaceuticals #publichealth #governmentpolicy #biotech #drugdevelopment #fda

Moderna's flu shot dilemma muddies 2028 break-even guidance

3 months / endpoints / Max Bayer

The Old System Failed Patients. Change Must Go Further and Faster – Garo Armen

3 months / oncodaily

PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarna

3 months / endpoints / Ayisha Sharma

FDA rejects Moderna's mRNA flu vaccine application, for reasons with no basis in the law

3 months / medicalxpress

What the Health? From KFF Health News: New Flu Vax? FDA Says No Thanks

3 months / kffhealthnews

Controversy around FDA’s Prasad rises again after Moderna rejection, behavior allegations